CA
LCTX icon

Corrado Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Corrado Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,547
Closed -$61K – 99
2018
Q3 		$61K Sell
29,547
-15,344
-34% -$32.2K 0.04% 99
2018
Q2 		$80K Hold
44,891
– – 0.05% 105
2018
Q1 		$106K Sell
44,891
-40,691
-48% -$95.4K 0.06% 114
2017
Q4 		$161K Buy
85,582
+1,143
+1% +$2.5K 0.09% 110
2017
Q3 		$210K Buy
84,439
+13,716
+19% +$34K 0.12% 106
2017
Q2 		$195K Hold
70,723
– – 0.11% 105
2017
Q1 		$213K Buy
70,723
+32,090
+83% +$91.1K 0.12% 97
2016
Q4 		$122K Buy
38,633
+2,286
+6% +$7.02K 0.08% 102
2016
Q3 		$124K Buy
+36,347
New +$100K 0.08% 99

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IA
IndexIQ Advisors New York $2.82B AUM 12.48% 1-Year Est. Return